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FAILURE OF AUREOMYCIN AND CHLOROMYCETIN (CHLORAI\{PHENICOL)
IN DERMATITIS HERPETIFORMIS
CLARENCE SHAW, M.D.
Chattanooga, Tennessee
A recent report (1) has indicated that Aureomycin is a valuable drug in the treatment
of dermatitis herpetiformis. In a small series of cases this antibiotic was reported as in-
variably effective in the relief of signs and symptoms of this disorder.
This report, based on a trial of Aureomycin and Chioromycetin (chioramphenicol) in
two patients with dermatitis herpetiformis, demonstrates the failure of these preparations
to influence the course of this disease in either patient.
CASE 1
Mr. B. G. P., a 41 year old machinist with dermatitis herpetiformis has been under ob-
servation since 1943. When the diagnosis was first established in 1940 he was given Fowler's
solution (solution of potassium arsenite) which he continued to take for over three years.
When first seen by me he had generalized pigmentation together with arsenical keratoses
on the palms and soles. The liver was palpably enlarged and there was pitting edema of the
ankles. He was placed on sulfapyridine which gave him considerable relief as long as he
continued to take it. Because of a flareup in August 1949, he was placed on Chloromycetin
(chloramphenicol) 250 mg. 4 times daily for two weeks, during which time the eruption
became worse. He was then given Aureomycin 250 mg. 4 times daily for two more weeks,
which also failed to give either objective or symptomatic improvement. Upon resump-
tion of sulfapyridine 0.5 gm. 4 times daily he again noted involution of the eruption.
CASE 2
Mrs. A. W., a 70 year old housewife, has been under observation for dermatitis herpeti-
formis since 1947. She was given sulfapyridine but was unable to tolerate it. With local
treatment, roentgen ray therapy and arsenic she remained reasonably comfortable until
this summer when she developed an acute flareup. She was given Chloromycetin (chlo-
ramphenicol) 250 mg. 4 times daily for two weeks during which time the eruption became
progressively worse. She was then placed on Aureomycin 250mg. 4 times daily for two weeks
with neither objective nor subjective improvement.
Results in these two patients indicate that neither Aureomycin nor Chloromycetin
(chloramphenicol) are specific in the doses used for the relief of signs and symptoms of
dermatitis herpetiformis.
REFERENCE
(1) Therapeutic Value of Aureomycin in Dermatitis Herpetiformis; H. M. RoBINsoN,
H. M. ROBINSON, JE., R. C. V. ROBINSON; J. Invest. Dermat.; 13:9 (July) 1949.
Received for publication September 30, 1949.
3
